Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers

Resistance to oestrogen-deprivation therapy is common in oestrogen-receptor-positive (ER+) breast cancer. To better understand the contributions of tumour heterogeneity and evolution to resistance, here we perform comprehensive genomic characterization of 22 primary tumours sampled before and after...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Christopher A., Gindin, Yevgeniy, Lu, Charles, Griffith, Obi L, Griffith, Malachi, Shen, Dong, Hoog, Jeremy, Li, Tiandao, Larson, David E., Watson, Mark, Davies, Sherri R, Hunt, Kelly, Suman, Vera J., Snider, Jacqueline, Walsh, Thomas, Colditz, Graham A., DeSchryver, Katherine, Wilson, Richard K., Mardis, Elaine R., Ellis, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980485/
https://www.ncbi.nlm.nih.gov/pubmed/27502118
http://dx.doi.org/10.1038/ncomms12498

Ejemplares similares

Ejemplares similares